Cancer and skin lesion treatment
AssigneeHpvvax, LLC
InventorTim Ioannides
Life of this patent
Estimating the term…
Abstract
A method for treating or reducing the incidence of recurrence of cancer, benign tumors or HPV-associated lesions, including skin cancer, and particularly squamous cell carcinoma (SCC and basal-cell carcinoma, by administering one or more doses of HPV recombinant vaccine to a patient.
Claims75
A method for treating a patient having cancer, said method comprising the steps of:
- a) administering to a patient 27 years of age or older or a patient previously not immunized with an HPV vaccine, a first dose of an HPV vaccine which is free of host-cell peptide, polypeptide, or protein or a degradant product thereof;
- b) administering to the patient a second dose of the HPV vaccine about one month to about three months after the first administration;
- and
- c) administering to the patient a third dose of the HPV vaccine about five months to about seven months after the first dose wherein the cancer is treated.
A method for treating a patient having cancer, said method comprising the step of:
- a) administering a dose of an HPV vaccine directly to the cancer or an area immediately surrounding the cancer.
A method for treating a patient having a cancerous tumor said method comprising the steps of:
- a) administering to a patient having a cancerous tumor, and being 27 years of age or older or a patient previously not immunized with an HPV vaccine, a first dose of an HPV vaccine comprising at least one viral L1 protein which is free of non-L1 viral peptide, polypeptide, or protein or a degradant product thereof;
- b) administering to the patient a second dose of the HPV vaccine about one month to about three months after the first administration;
- and
- c) administering to the patient a third dose of the HPV vaccine about five months to about seven months after the first dose.
A method for treating a patient having a cancerous tumor, said method comprising the step of:
- a) administering a dose of an HPV vaccine to patient with a cancerous tumor, wherein administration is directly into said tumor;
- and
- b) administering a second dose of HPV vaccine about two months after administering the first dose and the third dose of HPV vaccine is administered about six months after administering the first dose.
A method for treating a patient having cancer, said method comprising the step of:
- administering to a patient 27 years of age or older or a patient previously not immunized with an HPV vaccine, a first dose of an HPV vaccine which is free of host-cell peptide, polypeptide, or protein or a degradant product thereof,
- whereby the cancer is treated.
A method for treating a patient having cancer, said method comprising the step of:
- a) systemically administering to a patient 27 years of age or older or a patient previously not immunized with an HPV vaccine, a first dose of an HPV vaccine which is free of host-cell peptide, polypeptide, or protein or a degradant product thereof, and
- b) administering a dose of an HPV vaccine directly to the cancer or an area immediately surrounding the cancer,
- whereby the cancer is treated.
Dependencies are inferred from the claim text.